Myc transcription factors: key regulators behind establishment and maintenance of pluripotency

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Martin GR: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA78,7634–7638 (1981).
  Medline CASGoogle Scholar
• 2  Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science282,1145–1147 (1998).
  Medline CASGoogle Scholar
• 3  Evans M, Kaufman M: Establishment in culture of pluripotential cells from mouse embryos. Nature292(5819),154–156 (1981).
  Medline CASGoogle Scholar
• 4  Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126,663–676 (2006).▪▪ The first description of induced pluripotent stem (iPS) cells.
  Medline CASGoogle Scholar
• 5  Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131,861–872 (2007).
  Medline CASGoogle Scholar
• 6  Chin MH, Mason MJ, Xie W et al.: Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell5,111–123 (2009).
  Medline CASGoogle Scholar
• 7  Maherali N, Sridharan R, Xie W et al.: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell1,55–70 (2007).
  Medline CASGoogle Scholar
• 8  Loebel DAF, Watson CM, De Young RA, Tam PPL: Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev. Biol.264,1–14 (2003).
  Medline CASGoogle Scholar
• 9  Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature448,313–317 (2007).▪ In this study, therapeutic implications of iPS cells generated using exogenous Myc was indicated.
  Medline CASGoogle Scholar
• 10  Yamanaka S, Li J, Kania G et al.: Pluripotency of embryonic stem cells. Cell Tissue Res.331,5–22 (2008).
  MedlineGoogle Scholar
• 11  Yamanaka S: A fresh look at iPS cells. Cell137,13–17 (2009).
  Medline CASGoogle Scholar
• 12  Hochedlinger K, Plath K: Epigenetic reprogramming and induced pluripotency. Development136,509–523 (2009).
  Medline CASGoogle Scholar
• 13  Eisenman RN: Deconstructing Myc. Genes Dev.15,2023–2030 (2001).
  Medline CASGoogle Scholar
• 14  Levens DL: Reconstructing Myc. Genes Dev.17,1071–1077 (2003).
  Medline CASGoogle Scholar
• 15  Levens D: Disentangling the Myc web. Proc. Natl Acad. Sci. USA99,5757–5759 (2002).
  Medline CASGoogle Scholar
• 16  Cole MD, Henriksson M: 25 years of the c-Myc oncogene. Semin. Cancer Biol.16,241 (2006).
  MedlineGoogle Scholar
• 17  Meyer N, Penn LZ: Reflecting on 25 years with Myc. Nat. Rev. Cancer8,976–990 (2008).
  Medline CASGoogle Scholar
• 18  Adhikary S, Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol.6,635–645 (2005).
  Medline CASGoogle Scholar
• 19  Cotterman R, Jin VX, Krig SR et al.: N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res.68,9654–9662 (2008).
  Medline CASGoogle Scholar
• 20  Luscher B, Larsson LG: The basic region/helix–loop–helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene18,2955–2966 (1999).
  Medline CASGoogle Scholar
• 21  Brenner C, Deplus R, Didelot C et al.: Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J.24,336–346 (2005).
  Medline CASGoogle Scholar
• 22  Fernandez PC, Frank SR, Wang L et al.: Genomic targets of the human c-Myc protein. Genes Dev.17,1115–1129 (2003).▪ Demonstrates the potential for Myc to occupy and regulate numerous target genes.
  Medline CASGoogle Scholar
• 23  Blackwell T, Huang J, Ma A et al.: Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol.13,5216–5224 (1993).
  Medline CASGoogle Scholar
• 24  Eilers M, Eisenman RN: Myc’s broad reach. Genes Dev.22(20),2755–2766 (2008).
  Medline CASGoogle Scholar
• 25  Dang CV, O’Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F: The c-Myc target gene network. Semin. Cancer Biol.16,253–264 (2006).
  Medline CASGoogle Scholar
• 26  Blackwood E and Eisenman R: Max: a helix–loop–helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science251,1211–1217 (1991).
  Medline CASGoogle Scholar
• 27  Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H: Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell72,233–245 (1993).
  Medline CASGoogle Scholar
• 28  Ma A, Moroy T, Collum R, Weintraub H, Alt FW, Blackwell TK: DNA binding by N- and L-Myc proteins. Oncogene8,1093–1098 (1993).
  Medline CASGoogle Scholar
• 29  Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV: Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol. Cell. Biol.12,3130–3137 (1992).
  Medline CASGoogle Scholar
• 30  Dominguez-Sola D, Ying CY, Grandori C et al.: Non-transcriptional control of DNA replication by c-Myc. Nature448,445–451 (2007).
  Medline CASGoogle Scholar
• 31  Peukert K, Staller P, Schneider A, Carmichael G, Hänel F, Eilers M: An alternative pathway for gene regulation by Myc. EMBO J.16,5672 (1997).
  Medline CASGoogle Scholar
• 32  Philipp A, Schneider A, Vasrik I et al.: Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol.14,4032–4043 (1994).
  Medline CASGoogle Scholar
• 33  Arabi A, Wu S, Ridderstråle K et al.: c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat. Cell Biol.7,303–310 (2005).
  Medline CASGoogle Scholar
• 34  Gomez-Roman N, Grandori C, Eisenman RN, White RJ: Direct activation of RNA polymerase III transcription by c-Myc. Nature421,290–294 (2003).
  Medline CASGoogle Scholar
• 35  Cowling VH, Cole MD: The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol. Cell. Biol.27,2059–2073 (2007).
  Medline CASGoogle Scholar
• 36  Wert M, Kennedy S, Palfrey HC, Hay N: Myc drives apoptosis in PC12 cells in the absence of Max. Oncogene20,3746–3750 (2001).
  Medline CASGoogle Scholar
• 37  Secombe J, Li L, Carlos L, Eisenman RN: The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev.21,537 (2007).
  Medline CASGoogle Scholar
• 38  Orian A, van Steensel B, Delrow J et al.: Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev.17,1101–1114 (2003).
  Medline CASGoogle Scholar
• 39  Malynn BA, de Alboran IM, O’Hagan RC et al.: N-Myc can functionally replace c-Myc in murine development, cellular growth, and differentiation. Genes Dev.14,1390–1399 (2000).
  Medline CASGoogle Scholar
• 40  Zimmerman KA, Yancopoulos GD, Collum RG et al.: Differential expression of Myc family genes during murine development. Nature319(6056),780–783 (1986).
  Medline CASGoogle Scholar
• 41  Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss of N-Myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev.6,2235–2247 (1992).
  Medline CASGoogle Scholar
• 42  Charron J, Malynn BA, Fisher P et al.: Embryonic lethality in mice homozygous for a targeted disruption of the N-Myc gene. Genes Dev.6,2248–2257 (1992).
  Medline CASGoogle Scholar
• 43  Davis AC, Wims M, Spotts GD, Hann SR, Bradley A: A null c-Myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev.7,671–682 (1993).
  Medline CASGoogle Scholar
• 44  Trumpp A, Refaeli Y, Oskarsson T et al.: c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature414,768–773 (2001).
  Medline CASGoogle Scholar
• 45  Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ, Trumpp A: Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development135,2455–2465 (2008).
  Medline CASGoogle Scholar
• 46  Smith KN, Singh AM, Dalton S: Myc sustains pluripotency by repressing primitive endoderm specification. Cell Stem Cell7,343–354 (2010).▪ Defines mechanisms by which Myc sustains pluripotent stem cells, and suggests Myc is required for early embryonic development.
  Medline CASGoogle Scholar
• 47  Varlakhanova NV, Cotterman RF, deVries WN et al.: Myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation80,9–19 (2010).▪ Using doubly floxed alleles, this study demonstrates that Myc inhibits differentiation to maintain pluripotent stem cells, and suggests that Myc is required for early embryonic development.
  Medline CASGoogle Scholar
• 48  Hatton KS, Mahon K, Chin L et al.: Expression and activity of L-Myc in normal mouse development. Mol. Cell. Biol.16,1794–1804 (1996).
  Medline CASGoogle Scholar
• 49  Yi F, Jaffe R, Prochownik EV: The CCL6 chemokine is differentially regulated by c-Myc and L-Myc, and promotes tumorigenesis and metastasis 1. Cancer Res.63,2923–2932 (2003).
  Medline CASGoogle Scholar
• 50  Landay M, Oster SK, Khosravi F et al.: Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family. Cell Death Differ.7,697–705 (2000).
  Medline CASGoogle Scholar
• 51  Shen-Li H, O’Hagan RC, Hou H, Horner JW, Lee HW, DePinho RA: Essential role for Max in early embryonic growth and development. Genes Dev.14,17–22 (2000).
  Medline CASGoogle Scholar
• 52  Smith AG, Heath JK, Donaldson DD et al.: Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature336,688–690 (1988).
  Medline CASGoogle Scholar
• 53  Niwa H, Burdon T, Chambers I, Smith A: Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev.12,2048–2060 (1998).
  Medline CASGoogle Scholar
• 54  Ying QL, Nichols J, Chambers I, Smith A: BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell115,281–292 (2003).
  Medline CASGoogle Scholar
• 55  Boyer LA, Lee TI, Cole MF et al.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell122,947–956 (2005).
  Medline CASGoogle Scholar
• 56  Marson A, Levine SS, Cole MF et al.: Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell134,521–533 (2008).
  Medline CASGoogle Scholar
• 57  Boyer LA, Mathur D, Jaenisch R: Molecular control of pluripotency. Curr. Opin. Genet. Dev.16,455–462 (2006).
  Medline CASGoogle Scholar
• 58  Kim J, Chu J, Shen X, Wang J, Orkin SH: An extended transcriptional network for pluripotency of embryonic stem cells. Cell132,1049–1061 (2008).
  Medline CASGoogle Scholar
• 59  Wang J, Rao S, Chu J et al.: A protein interaction network for pluripotency of embryonic stem cells. Nature444,364–368 (2006).
  Medline CASGoogle Scholar
• 60  Liang J, Wan M, Zhang Y et al.: Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol.10,731–739 (2008).
  Medline CASGoogle Scholar
• 61  Boyer LA, Plath K, Zeitlinger J et al.: Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature441,349–353 (2006).
  Medline CASGoogle Scholar
• 62  Lee TI, Jenner RG, Boyer LA et al.: Control of developmental regulators by Polycomb in human embryonic stem cells. Cell125,301–313 (2006).
  Medline CASGoogle Scholar
• 63  Loh YH, Wu Q, Chew JL et al.: The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet.38,431–440 (2006).
  Medline CASGoogle Scholar
• 64  Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S: LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development132,885–896 (2005).
  Medline CASGoogle Scholar
• 65  Knoepfler PS, Cheng PF, Eisenman RN: N-Myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev.16,2699–2712 (2002).
  Medline CASGoogle Scholar
• 66  Okubo T, Knoepfler PS, Eisenman RN, Hogan BLM: N-myc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development132,1363 (2005).
  Medline CASGoogle Scholar
• 67  Laurenti E, Varnum-Finney B, Wilson A et al.: Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell3,611–624 (2008).▪ Demonstrates an absolute requirement for c- or N-Myc in maintaining hematopoietic stem cells.
  Medline CASGoogle Scholar
• 68  Wilson A, Murphy MJ, Oskarsson T et al.: c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev.18,2747–2763 (2004).
  Medline CASGoogle Scholar
• 69  Gandarillas A, Watt FM: c-Myc promotes differentiation of human epidermal stem cells. Genes Dev.11,2869–2882 (1997).
  Medline CASGoogle Scholar
• 70  Baudino TA, McKay C, Pendeville-Samain H et al.: c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev.16,2530–2543 (2002).
  Medline CASGoogle Scholar
• 71  Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S: Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl Acad. Sci. USA107(32),14152–14157 (2010).
  Medline CASGoogle Scholar
• 72  Hanna J, Markoulaki S, Mitalipova M et al.: Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell4,513–524 (2009).
  Medline CASGoogle Scholar
• 73  Chen X, Xu H, Yuan P et al.: Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell133,1106–1117 (2008).
  Medline CASGoogle Scholar
• 74  Kidder BL, Yang J, Palmer S: Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE3,e3932–e3932 (2008).
  MedlineGoogle Scholar
• 75  Sridharan R, Tchieu J, Mason MJ et al.: Role of the murine reprogramming factors in the induction of pluripotency. Cell136,364–377 (2009).▪▪ By analyzing transcriptional changes during the reprogramming process, this study demonstrates that Myc is solely responsible for widespread gene expression changes in iPS cell generation.
  Medline CASGoogle Scholar
• 76  Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ: A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev.23(7),837–848 (2009).
  Medline CASGoogle Scholar
• 77  Zeller KI, Zhao X, Lee CWH et al.: Global mapping of c-Myc binding sites and target gene networks in human B-cells. Proc. Natl Acad. Sci. USA103,17834–17839 (2006).
  Medline CASGoogle Scholar
• 78  Rahl PB, Lin CY, Seila AC et al.: c-Myc regulates transcriptional pause release. Cell141,432–435 (2010).▪▪ Implicates Myc as a regulator of large numbers of transcribed genes in embryonic stem cells owing to its role in Pol II pause–release.
  Medline CASGoogle Scholar
• 79  Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN: Myc influences global chromatin structure. EMBO J.25,2723–2734 (2006).▪▪ Initially demonstrated that globally Myc controls chromatin structure.
  Medline CASGoogle Scholar
• 80  White J, Dalton S: Cell cycle control of embryonic stem cells. Stem Cell Rev.1,131–138 (2005).
  Medline CASGoogle Scholar
• 81  Stead E, White J, Faast R et al.: Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene21,8320–8333 (2002).
  Medline CASGoogle Scholar
• 82  Faast R, White J, Cartwright P, Crocker L, Sarcevic B, Dalton S: CDK6–cyclin D3 activity in murine ES cells is resistant to inhibition by p16(INK4a). Oncogene23,491–502 (2004).
  Medline CASGoogle Scholar
• 83  White J, Stead E, Faast R, Conn S, Cartwright P, Dalton S: Developmental activation of the Rb–E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol. Biol. Cell.16,2018–2027 (2005).
  Medline CASGoogle Scholar
• 84  Goodrich DW, Wang NP, Qian YW, Lee EYHP, Lee WH: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell67,293–302 (1981).
  Google Scholar
• 85  Rustgi AK, Dyson N, Bernards R: Amino-terminal domains of c-Myc and N-Myc proteins mediate binding to the retinoblastoma gene product. Nature352(6335),541–544 (1991).
  Medline CASGoogle Scholar
• 86  Goodrich DW, Lee WH: Abrogation by c-Myc of G_l phase arrest induced by Rb protein but not by p53. Nature360,177–179 (1992).
  Medline CASGoogle Scholar
• 87  Kim VN: MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol.6,376–385 (2005).
  Medline CASGoogle Scholar
• 88  He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet.5,522–531 (2004).
  Medline CASGoogle Scholar
• 89  Lin CH, Jackson AL, Guo J, Linsley PS, Eisenman RN: Myc-regulated microRNAs attenuate embryonic stem cell differentiation. EMBO J.28,3157–3170 (2009).
  Medline CASGoogle Scholar
• 90  Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R: Embryonic stem cell-specific microRNAs regulate the G₁–S transition and promote rapid proliferation. Nat. Genet.40(12),1478–1483 (2008).
  Medline CASGoogle Scholar
• 91  O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature435,839–843 (2005).▪ Demonstrates the widespread impact of Myc on miRNA expression.
  MedlineGoogle Scholar
• 92  Northcott PA, Fernandez-L A, Hagan JP et al.: The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res.69,3249 (2009).
  Medline CASGoogle Scholar
• 93  Chen C, Ridzon D, Lee CT, Blake J, Sun Y, Strauss WM: Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets. Mamm. Genome18,316–327 (2007).
  Medline CASGoogle Scholar
• 94  Judson RL, Babiarz JE, Venere M, Blelloch R: Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol.27(5),459–461 (2009).
  Medline CASGoogle Scholar
• 95  Melton C, Judson RL, Blelloch R: Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature463,621–626 (2010).
  Medline CASGoogle Scholar
• 96  Chang TC, Yu D, Lee YS et al.: Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet.40,43–50 (2007).
  Medline CASGoogle Scholar
• 97  Liu Q, Fu H, Sun F et al.: miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res.36,5391 (2008).
  Medline CASGoogle Scholar
• 98  Meshorer E, Misteli T: Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol.7(7),540–546 (2006).
  Medline CASGoogle Scholar
• 99  Golob JL, Paige SL, Muskheli V, Pabon L, Murry CE: Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev. Dyn.237(5),1389–1398 (2008).
  Medline CASGoogle Scholar
• 100  Efroni S, Duttagupta R, Cheng J et al.: Global transcription in pluripotent embryonic stem cells. Cell Stem Cell2,437–447 (2008).
  Medline CASGoogle Scholar
• 101  Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR: An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc. Natl Acad. Sci. USA106,5187–5191 (2009).
  Medline CASGoogle Scholar
• 102  Martinato F, Cesaroni M, Amati B, Guccione E: Analysis of Myc-induced histone modifications on target chromatin. PLoS ONE3(11),e3650 (2008).
  MedlineGoogle Scholar
• 103  Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B: Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev.15,2069–2082 (2001).
  Medline CASGoogle Scholar
• 104  Koch HB, Zhang R, Verdoodt B et al.: Large-scale identification of c-Myc-associated proteins using a combined TAP/MudPIT approach. Cell Cycle6,205–217 (2007).
  Medline CASGoogle Scholar
• 105  Frank SR, Parisi T, Taubert S et al.: MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep.4,575–580 (2003).
  Medline CASGoogle Scholar
• 106  McMahon SB, Wood MA, Cole MD: The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol.20,556–562 (2000).
  Medline CASGoogle Scholar
• 107  Cheng SWG, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV: c-Myc interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet.22,102–105 (1999).
  Medline CASGoogle Scholar
• 108  Faiola F, Liu X, Lo S et al.: Dual regulation of c-Myc by p300 via acetylation-dependent control of myc protein turnover and coactivation of myc-induced transcription. Mol. Cell. Biol.25,10220–10234 (2005).
  Medline CASGoogle Scholar
• 109  Frank SR, Parisi T, Taubert S et al.: MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep.4,575 (2003).
  Medline CASGoogle Scholar
• 110  Dugan KA, Wood MA, Cole MD: TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis. Oncogene21,5835–5843 (2002).
  Medline CASGoogle Scholar
• 111  Szutorisz H, Dillon N: The epigenetic basis for embryonic stem cell pluripotency. Bioessays27(12),1286–1293 (2005).
  Medline CASGoogle Scholar
• 112  Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell125,315–326 (2006).
  Medline CASGoogle Scholar
• 113  Mikkelsen TS, Ku M, Jaffe DB et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. 448(7153),553–560 (2007).
  Google Scholar
• 114  Guccione E, Martinato F, Finocchiaro G et al.: Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol.8,764–770 (2006).
  Medline CASGoogle Scholar
• 115  Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K: Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev.20,1123–1136 (2006).
  Medline CASGoogle Scholar
• 116  Leon J, Ferrandiz N, Acosta JC, Delgado MD: Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis? Cell Cycle8(8),1148–1157 (2009).
  Medline CASGoogle Scholar
• 117  Sridharan R, Plath K: Illuminating the black box of reprogramming. Cell Stem Cell2,295–297 (2008).
  Medline CASGoogle Scholar
• 118  Huangfu D, Osafune K, Maehr R et al.: Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol.26,1269–1275 (2008).
  Medline CASGoogle Scholar
• 119  Shi Y, Do T: A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell2,525–528 (2008).
  Medline CASGoogle Scholar
• 120  Mikkelsen TS, Hanna J, Zhang X et al.: Dissecting direct reprogramming through integrative genomic analysis. Nature454,49–55 (2008).
  Medline CASGoogle Scholar
• 121  Marion RM, Strati K, Li H et al.: Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell4,141–154 (2009).
  Medline CASGoogle Scholar
• 122  Greenberg RA, O’Hagan RC, Deng H et al.: Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene18,1219–1226 (1999).
  Medline CASGoogle Scholar
• 123  Wang J, Xie LY, Allan S, Beach D, Hannon GJ: Myc activates telomerase. Genes Dev.12,1769–1774 (1998).
  Medline CASGoogle Scholar
• 124  Amabile G, Meissner A: Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol. Med.15,59–68 (2009).
  Medline CASGoogle Scholar
• 125  Maherali N, Hochedlinger K: Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell3,595–605 (2008).
  Medline CASGoogle Scholar
• 126  Eilers M, Schirm S, Bishop J: The Myc protein activates transcription of the α-prothymosin gene. EMBO J.10,133 (1991).
  Medline CASGoogle Scholar
• 127  Eilers M, Picard D, Yamamoto KR, Bishop JM: Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. 340(6228),66–68 (1989).
  Google Scholar
• 128  Bouchard C, Staller P, Eilers M: Control of cell proliferation by Myc. Trends Cell Biol.8,202–206 (1998).
  Medline CASGoogle Scholar
• 129  Hong H, Takahashi K, Ichisaka T et al.: Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature460,1132–1135 (2009).▪▪ Links the success of reprogramming to cell cycle and proliferation regulators.
  Medline CASGoogle Scholar
• 130  Hanna J, Saha K, Pando B et al.: Direct cell reprogramming is a stochastic process amenable to acceleration. Nature462,595–601 (2009).▪▪ Assesses the kinetics of the reprogramming process and links the success of reprogramming to cell cycle and proliferation regulators.
  Medline CASGoogle Scholar
• 131  Fontana L, Fiori ME, Albini S et al.: Antagomir-17–5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE3(5),e2236 (2008).
  MedlineGoogle Scholar
• 132  Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H: Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27Kip1 and p21Cip1. EMBO J.18,5310–5320 (1999).
  Medline CASGoogle Scholar
• 133  Mendell JT: miRiad roles for the miR-17–92 cluster in development and disease. Cell133,217–222 (2008).
  Medline CASGoogle Scholar
• 134  Singh AM, Dalton S: The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell5,141–149 (2009).
  Medline CASGoogle Scholar
• 135  Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318,1917–1920 (2007).
  Medline CASGoogle Scholar
• 136  Lin CH, Lin CW, Tanaka H, Fero ML, Eisenman RN: Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. 4(11),e7839 (2009).
  Google Scholar
• 137  Balzer E, Moss EG: Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol.4,16–25 (2007).
  Medline CASGoogle Scholar
• 138  Secombe J, Pierce SB, Eisenman RN: Myc: a weapon of mass destruction. Cell117,153–156 (2004).
  Medline CASGoogle Scholar
• 139  Nilsson JA, Cleveland JL: Myc pathways provoking cell suicide and cancer. Oncogene22,9007–9021 (2003).
  Medline CASGoogle Scholar
• 140  Jordan CT: Cancer stem cell biology: from leukemia to solid tumors. Curr. Opin. Cell Biol.16,708–712 (2004).
  Medline CASGoogle Scholar
• 141  Evans MJ, Kaufman MH: Establishment in culture of pluripotential cells from mouse embryos. Nature292,154–156 (1981).
  Medline CASGoogle Scholar
• 142  Hoffman B, Amanullah A, Shafarenko M, Liebermann DA: The proto-oncogene c-Myc in hematopoietic development and leukemogenesis. Oncogene21,3414–3421 (2002).
  Medline CASGoogle Scholar
• 143  Rowland BD, Peeper DS: KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer6,11–23 (2005).
  Google Scholar
• 144  Wang J, Wang H, Li Z et al.: c-Myc is required for maintenance of glioma cancer stem cells. PLoS ONE3(11),e3769 (2008).
  MedlineGoogle Scholar
• 145  Shachaf CM, Kopelman AM, Arvanitis C et al.: MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature431,1112–1117 (2004).
  Medline CASGoogle Scholar
• 146  Felsher DW, Bishop JM: Reversible tumorigenesis by MYC in hematopoietic lineages. Mol.Cell4,199–207 (1999).
  Medline CASGoogle Scholar
• 147  Jain M, Arvanitis C, Chu K et al.: Sustained loss of a neoplastic phenotype by brief inactivation of Myc. Science297,102–104 (2002).
  Medline CASGoogle Scholar
• 148  Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126,663–676 (2006).
  Medline CASGoogle Scholar
• 149  Aoi T, Yae K, Nakagawa M et al.: Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science321,699–702 (2008).
  Medline CASGoogle Scholar
• 150  Hanna J, Markoulaki S, Schorderet P et al.: Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell133,250–264 (2008).
  Medline CASGoogle Scholar
• 151  Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K: Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells26,2467–2474 (2008).
  Medline CASGoogle Scholar
• 152  Kim JB, Zaehres H, Wu G et al.: Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature454,646–650 (2008).
  Medline CASGoogle Scholar
• 153  Stadtfeld M, Brennand K, Hochedlinger K: Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr. Biol.18,890–894 (2008).
  Medline CASGoogle Scholar
• 154  Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature448,318–324 (2007).
  Medline CASGoogle Scholar
• 155  Park IH, Arora N, Huo H et al.: Disease-specific induced pluripotent stem cells. Cell134,877–886 (2008).
  Medline CASGoogle Scholar
• 156  Aasen T, Raya A, Barrero MJ et al.: Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol.26,1276–1284 (2008).
  Medline CASGoogle Scholar
• 157  Sun N, Panetta NJ, Gupta DM et al.: Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl Acad. Sci. USA106,15720–15725 (2009).
  Medline CASGoogle Scholar
• 158  Giorgetti A, Montserrat N, Rodriguez-Piza I, Azqueta C, Veiga A, Belmonte JCI: Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat. Protoc.5,811–820 (2010).
  Medline CASGoogle Scholar
• 159  Loh YH, Agarwal S, Park IH et al.: Generation of induced pluripotent stem cells from human blood. Blood113,5476–5479 (2009).
  Medline CASGoogle Scholar
• 160  Carette JE, Pruszak J, Varadarajan M et al.: Generation of iPSCs from cultured human malignant cells. Blood115,4039–4040 (2010).
  Medline CASGoogle Scholar
• 161  Wu Y, Zhang Y, Mishra A, Tardif SD, Hornsby PJ: Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts. Stem Cell Res.4(3),180–188 (2010).
  Medline CASGoogle Scholar
• 162  Liao J, Cui C, Chen S et al.: Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell4,11–15 (2009).
  Medline CASGoogle Scholar
• 163  Ezashi T, Telugu BPVL, Alexenko AP, Sachdev S, Sinha S, Roberts RM: Derivation of induced pluripotent stem cells from pig somatic cells. Proc. Natl Acad. Sci. USA106,10993 (2009).
  Medline CASGoogle Scholar
• 164  Shimada H, Nakada A, Hashimoto Y, Shigeno K, Shionoya Y, Nakamura T: Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol. Reprod. Dev.77(1),2 (2010).
  Medline CASGoogle Scholar
• 165  Honda A, Hirose M, Hatori M et al.: Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine. J. Biol. Chem.285(41),31362–31369 (2010).
  Medline CASGoogle Scholar
• 166  Lee TH, Song SH, Kim KL et al.: Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ. Res.106(1),120–128 (2010).
  Medline CASGoogle Scholar
• 167  Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858),1917–1920 (2007).
  Medline CASGoogle Scholar
• 168  Haase A, Olmer R, Schwanke K et al.: Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell5,434–441 (2009).
  Medline CASGoogle Scholar
• 169  Nakagawa M, Koyanagi M, Tanabe K et al.: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol.26,101–106 (2008).
  Medline CASGoogle Scholar
• 170  Wernig M, Meissner A, Cassady JP, Jaenisch R: c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell2,10–12 (2008).
  Medline CASGoogle Scholar
• 171  Aoki T, Ohnishi H, Oda Y et al.: Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-Myc. Tissue Eng. Part A16(7),2197–2206 (2010).
  Medline CASGoogle Scholar
• 172  Huangfu D, Maehr R, Guo W et al.: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol.26,795–797 (2008).
  Medline CASGoogle Scholar
• 173  Kim JB, Sebastiano V, Wu G et al.: Oct4-induced pluripotency in adult neural stem cells. Cell136,411–419 (2009).
  Medline CASGoogle Scholar
• 201  Myc Cancer Gene www.myccancergene.org
  Google Scholar